Kwality Pharmaceuticals Ltd

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that Mr. Neelmani Khemka (DIN: 09787109) Additional Director (Non-Executive and Independent) of the Company has tendered his resignation with effect from March 18 2023. The resignation letter will be taken on record at the ensuing Board Meeting of the Company.You are requested to please take on record the information as required to be disclosed by the Company pursuant to the Regulation 30(2) read with clause 7 and 7B of Para A Part A of Schedule III of SEBI (LODR) Regulations 2015 for change in Director.